🫡 Отрабатываем годный тестнет

Mitosis — блокчейн L1 с ликвидностью для улучшения DeFi опыта. Проект привлек $7M от Tier-2 инвесторов, как: Amber Group, Foresight Ventures, Folius Ventures и другие. Сейчас нам надо пройти их тестнет, и претендовать на дроп в будущем 🛀 👨‍💻 Что делать? 1️⃣ Берем тестовые токены в кране 2️⃣ Привязываем в кране Discord и Twitter 3️⃣ Получаем токены ежедневно кнопкой «Claim Daily Tokens» 4️⃣ Депозитим токены в пул на сайте в окно «Deposit» 💬 Скорый дедлайн, да и сам проект на хорошем уровне, на бычке такие активности могут очень хорошо порадовать))) 📆 Дедлайн: 22 декабря ARVIL КРИПТУЕТ 📞 | ЧАТ 👋

This is the live equity curve of the system I spent months building. It runs 24/7 across 12 pairs. I check the dashboard with coffee in the morning. Some days I forget to check it at all. Since live launch: +312% total return 2.41 Sharpe ratio 14.3% max drawdown 51.7% win rate 4,218 trades Best month: +34.2% Worst month: -8.1% This is live execution. Not a backtest. Not a sanitized slice of data pulled for marketing. The win rate will disappoint anyone raised on signal channels advertising 93%. Good. Win rate without expectancy is cosmetics. Over 4,000 trades, math has a way of humiliating hope. February was red. Parts of November were ugly. The curve has dents. If it didn’t, I’d trust the screenshot less than the system. Zoom out and the slope is still up. Consistently. Without me sitting in front of a screen at 3 a.m. negotiating with candles. Over the same period, BTC did roughly 48%. ETH did 31%. The system did 312%. Not by predicting the market. By removing myself from the execution loop. Tomorrow: why I won’t sell the system — and why copy trading would kill the edge in weeks.